This is a firm-fixed-price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The $15,377.00 contract is for the provision of an AXOPATCH 200B system, which is specialized electrophysiology equipment needed to perform experiments essential to the scientific mission of the NINDS laboratory. The award does not utilize any set-aside designation and has a completion date of February 24, 2026. Molecular Devices LLC is a leading manufacturer of high-performance bioanalytical measurement solutions and has received numerous prime federal contract awards from agencies like NIH, VA, USDA, FDA, and EPA for a range of products and services, including laboratory instruments, equipment, software, and related support.
Generated 2/26/25, 9:52 AM